对基于多糖的瘤向药物纳米递送系统的审查
Liangxing Tu1, Banghuai Xing1, Shufei Ma1
1Jiangxi University of Chinese Medicine, Nanchang 330006, PR China.
International journal of biological macromolecules
|February 11, 2025
概括
自然的多糖化合物通过使用纳米载体形成先进的瘤向药物递送系统 (TTDNS). 这些系统通过精确地向瘤输送药物来提高化疗的有效性,从而改善患者的治疗结果.
科学领域:
- 纳米技术纳米技术
- 在瘤学瘤学.
- 药物运输 药物运输 药物运输
背景情况:
- 化疗剂通常具有低生物可用性,高毒性和耐药性.
- 瘤向药物输送系统 (TTDNS) 使用纳米载体精确地将药物输送到瘤细胞,提高疗效.
- 天然多糖为TTDNS提供生物相容性,生物降解性和降低毒性.
研究的目的:
- 对TTDNS进行自然多糖的审查.
- 探索它们的抗瘤机制和纳米载体制备.
- 讨论基于多糖的纳米载体的应用和未来方向.
主要方法:
- 关于TTDNS中的天然多糖类的文献综述.
- 对多糖源和抗瘤机制的分析.
- 探索纳米载体制造方法 (纳米颗粒,纳米乳液等). ) 的情况.
主要成果:
- 基于多糖的纳米载体提高了药物的生物可用性,生物相容性和受控释放.
- 这些纳米载体在体内表现出向性和对刺激 (pH,ROS,光等) 的反应性. ) 的情况.
- 在瘤部位增加药物度可以提高治疗效果.
结论:
- 基于多糖的纳米载体显示出显著的希望,以增强化疗.
- 需要进一步的研究来改善体内稳定性,药物负载和瘤透性.
- 临床翻译需要创新的交付机制和广泛的研究.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


